Literature DB >> 21793975

Genetic alterations in microRNAs in medulloblastomas.

Sheng-Qing Lv1, Young-Ho Kim, Fiaschetti Giulio, Tarek Shalaby, Sumihito Nobusawa, Hui Yang, Zheng Zhou, Michael Grotzer, Hiroko Ohgaki.   

Abstract

MicroRNAs (miRNAs) regulate a variety of cellular processes via the regulation of multiple target genes. We screened 48 medulloblastomas for mutation, deletion and amplification of nine miRNA genes that were selected on the basis of the presence of potential target sequences within the 3'-untranslated region of the MYCC mRNA. Differential PCR revealed deletions in miR-186 (15%), miR-135a-1 (33%), miR-548d-1 (42%), miR-548d-2 (21%) and miR-512-2 (33%) genes, whereas deletion or amplification was detected in miR-135b (23%) and miR-135a-2 (15%). In miR-33b, deletion, amplification or a mutation at the precursor miRNA were detected in 10% of medulloblastomas. Overall, 35/48 (73%) medulloblastomas had at least one alteration. Real-time RT-PCR revealed MYCC overexpression in 11 of 37 (30%) medulloblastomas, and there was a correlation between MYCC overexpression and miR-512-2 gene deletion (P = 0.0084). Antisense-based knockdown of miR-512-5p (mature sequence of miR-512-2) resulted in significant upregulation of MYCC expression in HeLa and A549 cells, while forced overexpression of miR-512-2 in medulloblastoma/PNET cell lines DAOY, UW-228-2, PFSK resulted in the downregulation of MYCC protein. Furthermore, the results of luciferase reporter assays suggested that miR-512-2 targets the MYCC gene. These results suggest that alterations in the miRNA genes may be an alternative mechanism leading to MYCC overexpression in medulloblastomas.
© 2011 The Authors. Brain Pathology © 2011 International Society of Neuropathology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21793975     DOI: 10.1111/j.1750-3639.2011.00523.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  16 in total

Review 1.  Signaling pathway and molecular subgroups of medulloblastoma.

Authors:  Kay Ka-Wai Li; Kin-Mang Lau; Ho-Keung Ng
Journal:  Int J Clin Exp Pathol       Date:  2013-06-15

2.  MicroRNA-206 inhibits the viability and migration of medulloblastoma cells by targeting LIM and SH3 protein 1.

Authors:  Xuexia Pan; Zhimin Wang; Bin Wan; Zhenwen Zheng
Journal:  Exp Ther Med       Date:  2017-08-24       Impact factor: 2.447

3.  Upregulation of kazrin F by miR-186 suppresses apoptosis but promotes epithelial-mesenchymal transition to contribute to malignancy in human cervical cancer cells.

Authors:  Chang Liu; Jinghua Wang; Yang Hu; Hong Xie; Min Liu; Hua Tang
Journal:  Chin J Cancer Res       Date:  2017-02       Impact factor: 5.087

Review 4.  From small to big: microRNAs as new players in medulloblastomas.

Authors:  Feng Zhi; Suinuan Wang; Rong Wang; Xiwei Xia; Yilin Yang
Journal:  Tumour Biol       Date:  2012-11-25

Review 5.  Role of MYC in Medulloblastoma.

Authors:  Martine F Roussel; Giles W Robinson
Journal:  Cold Spring Harb Perspect Med       Date:  2013-11-01       Impact factor: 6.915

6.  MiR-138 and MiR-135 directly target focal adhesion kinase, inhibit cell invasion, and increase sensitivity to chemotherapy in cancer cells.

Authors:  Vita M Golubovskaya; Brittany Sumbler; Baotran Ho; Michael Yemma; William G Cance
Journal:  Anticancer Agents Med Chem       Date:  2014-01       Impact factor: 2.505

7.  MiR-186 suppresses the growth and metastasis of bladder cancer by targeting NSBP1.

Authors:  Kun Yao; Leye He; Yu Gan; Qing Zeng; Yingbo Dai; Jing Tan
Journal:  Diagn Pathol       Date:  2015-08-20       Impact factor: 2.644

Review 8.  Epigenetic-Based Therapy-A Prospective Chance for Medulloblastoma Patients' Recovery.

Authors:  Agata Strejczek; Dawid Woszczyk; Helena Urbaniak; Martyna Różańska; Michał Robak; Zofia Matuszewska; Anna-Maria Barciszewska
Journal:  Int J Mol Sci       Date:  2021-05-06       Impact factor: 5.923

9.  Downregulation of 14q32 microRNAs in Primary Human Desmoplastic Medulloblastoma.

Authors:  Danielle Ribeiro Lucon; Cristiane de Souza Rocha; Rogerio Bastos Craveiro; Dagmar Dilloo; Izilda A Cardinalli; Denise Pontes Cavalcanti; Simone Dos Santos Aguiar; Claudia Maurer-Morelli; Jose Andres Yunes
Journal:  Front Oncol       Date:  2013-09-25       Impact factor: 6.244

10.  MicroRNA-142 is mutated in about 20% of diffuse large B-cell lymphoma.

Authors:  Wiyada Kwanhian; Dido Lenze; Julia Alles; Natalie Motsch; Stephanie Barth; Celina Döll; Jochen Imig; Michael Hummel; Marianne Tinguely; Pankaj Trivedi; Viraphong Lulitanond; Gunter Meister; Christoph Renner; Friedrich A Grässer
Journal:  Cancer Med       Date:  2012-09-18       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.